Application of High Flow Nasal Cannula for Prevention of Post-extubation Atelectasis in Children Undergoing Surgery

March 5, 2019 updated by: Hee-Soo Kim, Seoul National University Hospital

Seoul National University Hospital Department of Anesthesiology and Pain Medicine

postoperative atelectasis observation by ultrasound after application of high flow nasal cannula oxygenation

Study Overview

Detailed Description

After surgery, postoperative atelectasis observation by ultrasound grading comparison between application of conventional nasal prong and high flow nasal cannula device

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of
        • Recruiting
        • Seoul National University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 day to 2 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • general anesthesia

Exclusion Criteria:

  • preterm
  • bronchopulmonary dysplasia
  • upper respiratory infection history
  • respiratory disease
  • cardiac surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: nasal prong
conventional nasal prong application after the surgery in postanesthetic care unit (PACU)
conventional nasal prong application in PACU
Experimental: high flow nasal cannula oxygenation
high flow nasal cannula application after the surgery in postanesthetic care unit (PACU)
high flow nasal cannula application in PACU

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
lung sound score
Time Frame: 30 minutes after arrival of postanesthetic care unit

0: Normal aeration (N): presence of lung sliding with A lines or fewer than two isolated B lines

  1. Moderate loss of lung aeration: multiple well-defined B lines (B1 lines)
  2. Severe loss of lung aeration: multiple coalescent B lines (B2 lines)
  3. Lung consolidation (C): the presence of a tissue pattern characterized by dynamic air
30 minutes after arrival of postanesthetic care unit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hee-Soo Kim, Seoul National University Children's Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 2, 2019

Primary Completion (Anticipated)

January 30, 2021

Study Completion (Anticipated)

June 30, 2021

Study Registration Dates

First Submitted

January 23, 2019

First Submitted That Met QC Criteria

January 23, 2019

First Posted (Actual)

January 25, 2019

Study Record Updates

Last Update Posted (Actual)

March 7, 2019

Last Update Submitted That Met QC Criteria

March 5, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 1812-111-998

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe